Skip to content

Clinical trials

Withdrawn Carcinoma, Intraductal, Noninfiltrating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Status: Withdrawn Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20102
20111
20121
20142
20151
20161
20192
20201
20222
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ohio State University Comprehensive Cancer Center2
Case Comprehensive Cancer Center1
Columbia University1
Duke University1
ETOP IBCSG Partners Foundation1
Eli Avisar, MD1
Fox Chase Cancer Center1
H. Lee Moffitt Cancer Center and Research Institute1
Jaroslaw Hepel1
Larkin Community Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating18
Breast Neoplasms14
Breast Carcinoma In Situ6
Carcinoma, Ductal, Breast3
Carcinoma, Lobular2
Breast Neoplasms, Male1
Cicatrix1
Fibroadenoma1
Osteoporosis1
Phyllodes Tumor1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.